company background image
CUTR

CuteraNasdaqGS:CUTR Stock Report

Market Cap

US$735.1m

7D

-3.8%

1Y

114.5%

Updated

27 Oct, 2021

Data

Company Financials +
CUTR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health2/6
Dividends0/6

CUTR Overview

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide.

Cutera Competitors

InMode

NasdaqGS:INMD

US$6.3b

Apyx Medical

NasdaqGS:APYX

US$485.7m

Misonix

NasdaqGM:MSON

US$441.6m

FONAR

NasdaqCM:FONR

US$106.1m

Price History & Performance

Summary of all time highs, changes and price drops for Cutera
Historical stock prices
Current Share PriceUS$40.97
52 Week HighUS$18.22
52 Week LowUS$60.36
Beta1.64
1 Month Change-13.05%
3 Month Change-19.86%
1 Year Change114.50%
3 Year Change101.82%
5 Year Change212.75%
Change since IPO192.64%

Recent News & Updates

Sep 17
Is Cutera (NASDAQ:CUTR) A Risky Investment?

Is Cutera (NASDAQ:CUTR) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Aug 13
Cutera's (NASDAQ:CUTR) Promising Earnings May Rest On Soft Foundations

Cutera's (NASDAQ:CUTR) Promising Earnings May Rest On Soft Foundations

Cutera, Inc. ( NASDAQ:CUTR ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

Shareholder Returns

CUTRUS Medical EquipmentUS Market
7D-3.8%2.0%0.9%
1Y114.5%24.4%33.4%

Return vs Industry: CUTR exceeded the US Medical Equipment industry which returned 24.4% over the past year.

Return vs Market: CUTR exceeded the US Market which returned 33.4% over the past year.

Price Volatility

Is CUTR's price volatile compared to industry and market?
CUTR volatility
CUTR Beta1.64
Industry Beta0.88
Market Beta1

Stable Share Price: CUTR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CUTR's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988323Dave Mowryhttps://cutera.com

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women’s intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity.

Cutera Fundamentals Summary

How do Cutera's earnings and revenue compare to its market cap?
CUTR fundamental statistics
Market CapUS$735.10m
Earnings (TTM)US$7.32m
Revenue (TTM)US$197.33m

100.5x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CUTR income statement (TTM)
RevenueUS$197.33m
Cost of RevenueUS$86.02m
Gross ProfitUS$111.31m
ExpensesUS$103.99m
EarningsUS$7.32m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Nov 03, 2021

Earnings per share (EPS)0.41
Gross Margin56.41%
Net Profit Margin3.71%
Debt/Equity Ratio250.8%

How did CUTR perform over the long term?

See historical performance and comparison

Valuation

Is Cutera undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CUTR ($40.97) is trading below our estimate of fair value ($146.56)

Significantly Below Fair Value: CUTR is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CUTR is poor value based on its PE Ratio (100.5x) compared to the US Medical Equipment industry average (49.9x).

PE vs Market: CUTR is poor value based on its PE Ratio (100.5x) compared to the US market (18.1x).


Price to Earnings Growth Ratio

PEG Ratio: CUTR is poor value based on its PEG Ratio (44x)


Price to Book Ratio

PB vs Industry: CUTR is overvalued based on its PB Ratio (13.8x) compared to the US Medical Equipment industry average (4.3x).


Future Growth

How is Cutera forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

2.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CUTR's forecast earnings growth (2.3% per year) is above the savings rate (2%).

Earnings vs Market: CUTR's earnings (2.3% per year) are forecast to grow slower than the US market (14.7% per year).

High Growth Earnings: CUTR's earnings are forecast to grow, but not significantly.

Revenue vs Market: CUTR's revenue (15.3% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: CUTR's revenue (15.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CUTR's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Cutera performed over the past 5 years?

-36.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CUTR has a large one-off gain of $6.4M impacting its June 30 2021 financial results.

Growing Profit Margin: CUTR became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: CUTR has become profitable over the past 5 years, growing earnings by -36.8% per year.

Accelerating Growth: CUTR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CUTR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (36.1%).


Return on Equity

High ROE: CUTR's Return on Equity (13.7%) is considered low.


Financial Health

How is Cutera's financial position?


Financial Position Analysis

Short Term Liabilities: CUTR's short term assets ($238.6M) exceed its short term liabilities ($60.3M).

Long Term Liabilities: CUTR's short term assets ($238.6M) exceed its long term liabilities ($150.5M).


Debt to Equity History and Analysis

Debt Level: CUTR's debt to equity ratio (250.8%) is considered high.

Reducing Debt: Insufficient data to determine if CUTR's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CUTR's debt is not well covered by operating cash flow (4.4%).

Interest Coverage: CUTR's interest payments on its debt are not well covered by EBIT (1.4x coverage).


Balance Sheet


Dividend

What is Cutera current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CUTR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CUTR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CUTR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CUTR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CUTR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Dave Mowry (59 yo)

2.25yrs

Tenure

US$1,334,582

Compensation

Mr. David H. Mowry, also known as Dave, has been Independent Director of Alphatec Holdings, Inc. (alternative name Alphatec Spine, Inc.) since February 8, 2017. He is the Chief Executive Officer and Direct...


CEO Compensation Analysis

Compensation vs Market: Dave's total compensation ($USD1.33M) is below average for companies of similar size in the US market ($USD2.26M).

Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CUTR's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

Experienced Board: CUTR's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CUTR insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cutera, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Cutera, Inc.
  • Ticker: CUTR
  • Exchange: NasdaqGS
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$735.102m
  • Shares outstanding: 17.94m
  • Website: https://cutera.com

Number of Employees


Location

  • Cutera, Inc.
  • 3240 Bayshore Boulevard
  • Brisbane
  • California
  • 94005
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/27 22:56
End of Day Share Price2021/10/27 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.